COMPARISON OF NUCLEOSIDE/NUCLEOTIDE ANALOGS FOR PREVENTING REACTIVATION OF HEPATITIS B VIRUS (HBV) IN IMMUNOCOMPROMISED/HSCT PATIENTS. Presented by Francesca.
